INTS
INTENSITY THERP (INTS)
NASDAQ
$4.00-$0.02 (-0.62%)
Price as of Jun 03, 2026 7:34 PM EDT
  • $11.9M
    Market Cap
  • -66.50%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-6.8M
-35.36%
-10.5M
+119.31%
-4.8M
N/A
Depreciation and Amortization Expense
N/A
N/A
N/A
N/A
N/A
N/A
Total Operating Expenses
12.0M
-27.81%
16.6M
+99.36%
8.3M
N/A
Operating Profit
-12.0M
-27.81%
-16.6M
+99.36%
-8.3M
N/A
Interest Income
180,000
-42.68%
314,000
-3.09%
324,000
N/A
Interest Expense
N/A
N/A
-145,000
-52.46%
-305,000
N/A
Interest Income and Expense and Net
180,000
+6.51%
169,000
+789.47%
19,000
N/A
Total Nonoperating Income and Expense
186,000
+6,100.00%
3,000
-87.50%
24,000
N/A
Income before Taxes
-12.0M
-27.81%
-16.6M
+99.36%
-8.3M
N/A
Income Taxes
0
N/A
0
N/A
0
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-11.6M
-28.66%
-16.3M
+54.37%
-10.5M
N/A
Net Income from Continuing Operations Applicable to Common
-11.6M
-28.66%
-16.3M
+37.14%
-11.9M
N/A
Basic EPS and Net Income
-8.56
+631.62%
-1.17
-15.22%
-1.38
N/A
Diluted EPS and Net Income
-8.56
+631.62%
-1.17
-15.22%
-1.38
N/A
Basic Weighted Average Shares
1.4M
-90.25%
13.9M
+61.40%
8.6M
N/A
Diluted Weighted Average Shares
1.4M
-90.25%
13.9M
+61.40%
8.6M
N/A
Balance Sheet
Cash and Cash Equivalents
11.9M
+360.27%
2.6M
-69.73%
8.6M
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
11.9M
+360.27%
2.6M
-69.73%
8.6M
N/A
Total Current Assets
12.7M
+277.91%
3.4M
-78.25%
15.5M
N/A
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Assets
1.3M
-0.15%
1.3M
-22.92%
1.7M
N/A
Total Assets
14.1M
+194.81%
4.8M
-72.34%
17.3M
N/A
Income Taxes Payable
1,800
0.00%
1,800
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
2.1M
+22.28%
1.8M
-55.67%
4.0M
N/A
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
79,000
N/A
0
-100.00%
36,000
N/A
Total Liabilities
2.2M
+19.30%
1.9M
-54.88%
4.1M
N/A
Retained Earnings
-78.4M
+17.38%
-66.8M
+32.20%
-50.5M
N/A
Total Stockholders Equity
11.9M
+306.99%
2.9M
-77.83%
13.2M
N/A
Total Shares Outstanding
2.5M
-83.31%
15.1M
+10.31%
13.7M
N/A
Cash Flow
Cash from Operating Activities
-9.2M
-39.34%
-15.2M
+111.24%
-7.2M
N/A
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
0
-100.00%
6.4M
+205.50%
-6.0M
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
18.6M
+540.14%
2.9M
-85.83%
20.5M
N/A
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-122.92%
-16.59%
-147.37%
N/A
N/A
N/A
Return on Equity
-156.90%
-22.46%
-202.34%
N/A
N/A
N/A
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
5.92
+209.06%
1.92
N/A
N/A
N/A
Cash Ratio
5.56
+276.41%
1.48
N/A
N/A
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow